Martin Reeves is Chairman of the BCG Henderson Institute, BCG’s think tank dedicated to exploring and developing valuable new insights from business, technology, economics, and science by embracing the powerful technology of ideas.
Martin is a regular contributor to Harvard Business Review, MIT Sloan Management Review, Fortune, and other management journals on business strategy and management.
A regular public speaker and a repeat TED@BCG presenter, Martin is coauthor of The Imagination Machine, an executive’s guide to systematically harnessing imagination for corporate reinvention and rejuvenation. He also coauthored Your Strategy Needs a Strategy, which proposes the “strategy palette” as a tool to enable business leaders to tune their approach to strategy to the strategic environment of each business.
Companies must increasingly compete on imagination, but we don’t have a clear idea of how imagination works or how to systematically improve it. How could we cultivate imaginative capacity, rather than leaving it to chance, intuition, or processes?
We attempt to distill the lessons from two truly ambitious projects—NASA’s Apollo program and Pfizer’s Lightspeed project—and show how, to succeed, projects and organizations must resolve the tensions between ingenuity and control.
As the pandemic marks a third anniversary, business leaders around the world are eager to move on. But few companies have systematically institutionalized what they’ve learned from their Covid-19 experience to build resilience.
In the increasingly politicized environment, leaders face the choice of leaning into politics or having the courage of restraint by limiting engagement. We argue they should choose restraint, for the sake of business and society.
Most leaders agree that imagination in business is crucial for success but they struggle to cultivate this capability. Explore how to harness the power of imagination.
The world of strategy is thick with ideas and frameworks; Your Strategy Needs a Strategy will help you cut through the noise and find clarity regarding which approach, or combination of approaches, is your best bet.
Inspiring and thought-provoking conversations with authors about influential ideas on business, technology, economics, and science.
Listen to Roger L. Martin, Professor Emeritus and former Dean at Rotman School of Management, as he discusses his new book, A New Way to Think, exploring the importance of human ingenuity, change, and, competitive advantage in reinventing the future.
Pfizer CEO Albert Bourla shares the story of the creation of the mRNA COVID-19 vaccine on our Thinkers and Ideas podcast.
Join Lynda Gratton is a Professor of Management Practice at London Business School as she explains how to deliberately redesign work taking into account not only the specifics of each job, but also a range of other technological, social and ethical factors.
“The history of the 20th century was about making people be better machines (…) the 21st century is going to be about making business more human.”
"We can never assume that our comfortable, safe lives in a democratic capitalist society are going to go on forever if we don’t do anything for it. The system is wonderful, but it’s also fragile."
As the pandemic marks a third anniversary, business leaders around the world are eager to move on. But few companies have systematically institutionalized what they’ve learned from their Covid-19 experience to build resilience.
We attempt to distill the lessons from two truly ambitious projects—NASA’s Apollo program and Pfizer’s Lightspeed project—and show how, to succeed, projects and organizations must resolve the tensions between ingenuity and control.
“It's time to bridge different domains and show how technology and finance are driving forces for sustainability. With this book, we wanted to tear down barriers and maximize the synergies between these three distinct fields.”
The uses and limits of large language models.
“It's not that intermediaries are bad, but we need to be smart about the role they play, and smart about the risks associated with their size and their multiplicity.”
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |